Entecavir is a nucleoside analog (more specifically, a guanosine analogue) that inhibits about-face transcription, DNA archetype and archetype in the viral archetype process. The drug's architect claims that entecavir is added alive than antecedent agents acclimated to amusement hepatitis B (lamivudine and adefovir).
Entecavir was accustomed by the U.S.FDA in March 2005.
USES Entecavir is acclimated to amusement abiding hepatitis B. It aswell helps anticipate the hepatitis B virus from adding and infecting new alarmist cells. Entecavir is aswell adumbrated for the analysis of abiding hepatitis B in adults with HIV/AIDS infection. However, entecavir is not alive adjoin HIV.
Clinical Trials
The analytic ability of entecavir has been advised in several randomized, double-blind, multicentre trials. Articulate entecavir was an able and about able-bodied acceptable treatment.
More about; Entecavir for sale
From:pharma products